buspirone has been researched along with Syndrome in 7 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dextromethorphan, a noncompetitive blocker of the N-methyl-D-aspartate (NMDA) type of glutamate receptor, at 45, 60 and 75 mg/kg, ip doses induced a behavioural syndrome characterised by reciprocal forepaw treading, lateral head-weaving, hind-limb abduction and flat body posture." | 7.73 | Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats. ( Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA; Thorat, VM, 2005) |
| "Dextromethorphan, a noncompetitive blocker of the N-methyl-D-aspartate (NMDA) type of glutamate receptor, at 45, 60 and 75 mg/kg, ip doses induced a behavioural syndrome characterised by reciprocal forepaw treading, lateral head-weaving, hind-limb abduction and flat body posture." | 3.73 | Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats. ( Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA; Thorat, VM, 2005) |
| " The interaction between tianeptine and drugs known to interfere with the uptake or release of serotonin (sertraline, buspirone, D-norfenfluramine) was then studied and, to ascertain the in vivo pharmacological relevance of tianeptine's effects, its ability to reduce the serotoninergic syndrome was evaluated." | 3.68 | In vivo studies on the enhancement of serotonin reuptake by tianeptine. ( Clavenna, A; De Luigi, A; De Simoni, MG; Manfridi, A, 1992) |
| "Buspirone, gepirone and ipsaperone administered intraperitoneally (40 mg/kg) to naive rats were found to be proconvulsive for strychnine-induced seizures." | 3.67 | Strychnine seizure potentiation by azaspirodecanedione anxiolytics in rats. ( Anderson, MC; Chung, E; Van Woert, MH, 1988) |
| "Kleptomania is currently classified in psychiatric nomenclature as one of the impulse control disorders (DSM-IV, 1994)." | 1.30 | [Kleptomania: phenomenological, clinical and legal aspects]. ( Durst, R; Jabotinsky-Rubin, K; Katz, G; Knobler, HY, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaikwad, RV | 1 |
| Gaonkar, RK | 1 |
| Jadhav, SA | 1 |
| Thorat, VM | 1 |
| Jadhav, JH | 1 |
| Balsara, JJ | 1 |
| Baetz, M | 1 |
| Malcolm, D | 1 |
| Nijhawan, PK | 1 |
| Katz, G | 2 |
| Winter, S | 1 |
| Durst, R | 1 |
| Jabotinsky-Rubin, K | 1 |
| Knobler, HY | 1 |
| Carrazana, EJ | 1 |
| Rivas-Vazquez, RA | 1 |
| Rey, JA | 1 |
| Rey, GJ | 1 |
| De Simoni, MG | 1 |
| De Luigi, A | 1 |
| Clavenna, A | 1 |
| Manfridi, A | 1 |
| Anderson, MC | 1 |
| Chung, E | 1 |
| Van Woert, MH | 1 |
7 other studies available for buspirone and Syndrome
| Article | Year |
|---|---|
Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antitussive Agents; Behavior, Animal; Buspirone; Ce | 2005 |
Serotonin syndrome from fluvoxamine and buspirone.
Topics: Buspirone; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive D | 1995 |
Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission.
Topics: Alcohol Withdrawal Delirium; Buspirone; Clomipramine; Diagnosis, Differential; Drug Therapy, Combina | 1996 |
[Kleptomania: phenomenological, clinical and legal aspects].
Topics: Adult; Buspirone; Disruptive, Impulse Control, and Conduct Disorders; Fluvoxamine; Humans; Male; Obs | 1997 |
SSRI discontinuation and buspirone.
Topics: Acute Disease; Buspirone; Depressive Disorder; Down-Regulation; Female; Humans; Middle Aged; Recepto | 2001 |
In vivo studies on the enhancement of serotonin reuptake by tianeptine.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents, Tricyclic; Buspirone; Drug Interactions; Hydroxyind | 1992 |
Strychnine seizure potentiation by azaspirodecanedione anxiolytics in rats.
Topics: Animals; Anti-Anxiety Agents; Buspirone; Drug Synergism; Male; Olivary Nucleus; Pyridines; Pyrimidin | 1988 |